Treatment outcomes of switching to aflibercept 8 mg in previously-treated neovascular age-related macular degeneration

Graefes Arch Clin Exp Ophthalmol. 2026 Jan;264(1):81-89. doi: 10.1007/s00417-025-06979-3.

Summary

nAMD Switch to Eylea HD extends treatment interval while maintaining VA and reducing CMT and PED height. Retrospective, 121 eyes.

Abstract

No abstract available.